Category: Uncategorized

n January 27, 2026, Neurocrine Biosciences announced the commencement of a Phase II clinical trial for NBI-1065890. This investigational compound... Read more

On January 27, 2026, the pharmaceutical innovation hub BioMed X announced a strategic partnership with the Government of Barbados to... Read more

On January 27, 2026, ICON plc, a global leader in clinical research, officially inaugurated the Brian Moran Cancer Institute at... Read more

On January 27, 2026, Integrated Biosciences, a Redwood City-based biotechnology firm, announced the appointment of Daniel J. Anderson, PhD, as... Read more

A recent strategic report by KPMG highlights a significant shift in technological priorities among life sciences executives. The Internet of... Read more

According to the latest update from the World Health Organization (WHO) European Regional Verification Commission, the United Kingdom, alongside Armenia,... Read more

The pharmaceutical company Roche has released positive topline data from its Phase II clinical trial (CT388-103) evaluating CT-388, an investigational... Read more

Following nearly two decades of negotiations, the European Union (EU) and India formally reached a comprehensive free trade agreement (FTA)... Read more

The U.S. federal government has identified 15 additional high-expenditure drugs to undergo price discussions aimed at lowering costs for the... Read more